Press release
Next-Generation Sequencing (NGS) Market Size, Share, Growth, Trends and Forecast 2024-2032
According to IMARC Group, the global next-generation sequencing (NGS) market size reached US$ 20.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 80.4 Billion by 2032, exhibiting a growth rate (CAGR) of 16.2% during 2024-2032.Global Next-Generation Sequencing (NGS) Market Trends:
The market growth of Next-Generation Sequencing (NGS) is primarily driven by the declining costs of sequencing procedures, which have made these technologies more accessible to a wider range of research institutions and healthcare providers. Advancements in NGS technologies have significantly increased the speed and efficiency of sequencing, enabling the rapid analysis of large volumes of genetic data. This capability is crucial for personalized medicine, genetic research, and clinical diagnostics, fostering a greater demand for NGS. Additionally, the rise in genomic research activities and an increasing emphasis on customized healthcare solutions further propel the market's expansion. The integration of artificial intelligence and machine learning in NGS data analysis enhances data accuracy and interpretation, attracting investment and research interest in this field.
Get Sample Copy of Report at - https://www.imarcgroup.com/next-generation-sequencing-market/requestsample
Factors Affecting the Growth of the Next-Generation Sequencing (NGS) Industry:
• Technological Advancements:
Technological advancements in Next-Generation Sequencing (NGS) have significantly propelled the market's growth. The introduction of high-throughput sequencing technologies has dramatically reduced the cost and increased the speed of sequencing, making genomic research more accessible and efficient. Innovations such as single-cell sequencing, long-read sequencing technologies, and improvements in data analysis software have expanded the applicability of NGS across various domains including oncology, genetic disorders, and agriculture. These advancements have enabled more detailed and accurate genomic analysis, facilitating personalized medicine, population genetics studies, and the identification of novel genetic markers. As technology continues to evolve, the potential for new applications and increased adoption of NGS is expected to further drive market growth.
• Increasing Clinical Applications:
The expansion of clinical applications for Next-Generation Sequencing is a significant factor driving its market growth. NGS technologies are increasingly being integrated into clinical practice for diagnostic purposes, personalized treatment planning, and disease susceptibility assessments. The ability of NGS to provide comprehensive genomic information has made it a crucial tool in precision medicine, especially in oncology for identifying targetable mutations and guiding therapy decisions. Furthermore, the use of NGS in prenatal screening, infectious disease identification, and rare genetic disorder diagnosis has underscored its versatility and impact on improving patient outcomes. As clinical evidence supporting the efficacy of NGS-based tests grows, regulatory approvals increase, and reimbursement scenarios improve, the adoption of NGS in clinical settings is expected to rise significantly.
• Government and Private Funding:
The growth of the Next-Generation Sequencing market is heavily influenced by government and private funding. Investment in genomics research has been a priority for many countries, aiming to advance healthcare, agriculture, and biotechnology. Government initiatives like the Genomic Medicine Program and private investments from pharmaceutical and biotech companies have provided substantial financial support for NGS research and development projects. This funding has facilitated the development of new NGS technologies, reduced sequencing costs, and supported large-scale genomics projects such as population genomics studies and cancer genomics consortia. Increased funding not only drives innovation but also promotes the adoption of NGS technologies by reducing financial barriers for research institutions and healthcare providers, thus stimulating market growth.
Next-Generation Sequencing (NGS) Market Report Segmentation:
Breakup by Sequencing Type:
• Whole Genome Sequencing
• Targeted Resequencing
• Whole Exome Sequencing
• RNA Sequencing
• CHIP Sequencing
• De Novo Sequencing
• Methyl Sequencing
• Others
Targeted Resequencing represented the largest segment due to its efficiency in focusing on specific genomic regions of interest, enhancing mutation detection accuracy.
Breakup by Product Type:
• Instruments
• Reagents and Consumables
• Software and Services
Reagents and Consumables represented the largest segment because of their recurring need in every sequencing procedure, driving continuous demand.
Breakup by Technology:
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Single-Molecule Real-Time Sequencing
• Nanopore Sequencing
• Others
Sequencing by Synthesis represented the largest segment as it is the most widely adopted method, offering high throughput and accuracy.
Breakup by Application:
• Biomarker and Cancer
• Drug Discovery and Personalized Medicine
• Genetic Screening
• Diagnostics
• Agriculture and Animal Research
• Others
Biomarker and Cancer represented the largest segment, reflecting the critical role of NGS in identifying genetic markers for cancer diagnosis and treatment.
Breakup by End-User:
• Academic Institutes & Research Centers
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others
Academic Institutes & Research Centers represented the largest segment, highlighting their leading role in conducting genomic research and NGS technology development.
Breakup by Region:
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa
North America emerged as the largest market, attributed to advanced healthcare infrastructure, significant investment in R&D, and the presence of leading genomics companies.
Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=2039&flag=C
Competitive Landscape With Key Players:
The competitive landscape of the global next-generation sequencing market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
• Agilent Technologies
• Becton Dickinson and Company
• 10x Genomics
• BGI Group
• Eurofins Scientific
• F. Hoffmann-La Roche AG
• Illumina Inc.
• Genewiz, Macrogen
• Oxford Nanopore Technologies
• Pacific Biosciences
• PerkinElmer
• Thermo Fisher Scientific
• Qiagen N.V.
• GenapSys Inc.
Key Highlights of the Report:
• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next-Generation Sequencing (NGS) Market Size, Share, Growth, Trends and Forecast 2024-2032 here
News-ID: 3382939 • Views: …
More Releases from IMARC Group

GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: …
GCC Pet Food Market Overview
Market Size in 2024: USD 266.2 Million
Market Size in 2033: USD 422.9 Million
Market Growth Rate 2025-2033: 5.3%
According to IMARC Group's latest research publication, "GCC Pet Food Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC pet food market size was valued at USD 266.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 422.9 Million by 2033, exhibiting a…

GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | Wi …
GCC Residential Real Estate Market Overview
Market Size in 2024: USD 73.31 Billion
Market Size in 2033: USD 147.77 Billion
Market Growth Rate 2025-2033: 7.50%
According to IMARC Group's latest research publication, "GCC Residential Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC residential real estate market size was valued at USD 73.31 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 147.77 Billion by…

GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAG …
GCC Drones Market Overview
Market Size in 2024: USD 588.2 Million
Market Size in 2033: USD 2,005.3 Million
Market Growth Rate 2025-2033: 13.3%
According to IMARC Group's latest research publication, "GCC Drones Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The GCC drones market size was valued at USD 588.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,005.3 Million by 2033, exhibiting a growth rate of…

Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Market Overview:
The medical imaging market is experiencing rapid growth, driven by Growing Burden of Chronic and Age-Related Diseases, Expansion of Government-Funded Health Infrastructure and Technological Advancements in Imaging Modalities. According to IMARC Group's latest research publication, "Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach…
More Releases for NGS
Next Generation Sequencing (NGS) : - Key Industry Dynamics
The Next Generation Sequencing (NGS) market size is projected to reach US$ 34.75 billion by 2031 from US$ 10.00 billion in 2023. The market is expected to register a CAGR of 16.8% during 2023-2031. Increased throughput and reduced costs is likely to remain key trends in the market.
Next-generation sequencing (NGS) carries a shift in genomics research, offering unmatched capabilities for analyzing DNA and RNA molecules in a high-throughput and cost-effective…
Next-Generation Sequencing (NGS) Services Next-Generation Sequencing (NGS) Servi …
Global Next-Generation Sequencing (NGS) Services Market Report encompasses market data, such as trends, consumer behavior, and competitive analysis in a way that allows businesses to identify opportunities in the market. The objective of the market research is understood very clearly by DBMR team before the creation of report commences. Intense research takes place to accurately analyze market dynamics and consumer behaviour included in the report.
Global Next-Generation Sequencing (NGS) Services Market,…
Complete PDF Guide to NGS Sample Preparation
The NGS sample preparations determine components in the samples, such as blood, urine, and others, in animals.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 @ https://www.theinsightpartners.com/sample/TIPRE00006573?utm_source=OpenPR&utm_medium=10379
The type of analyzers includes urine analyzers, blood gas & electrolyte analyzers, glucometers, and others used by medical labs, hospitals, and people at home.
Top Companies Analysis -
Agilent Technologies, Inc.
Becton, Dickinson and Company
Beckman Coulter
F. Hoffmann-La Roche AG
Illumina, Inc.
…
NGS Sample Preparation Market - Preparing for Precision: NGS Sample Preparation …
Newark, New Castle, USA: The "NGS Sample Preparation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
NGS Sample Preparation Market: https://www.growthplusreports.com/report/ngs-sample-preparation-market/8504
This latest report researches the industry structure,…
NGS Library Preparation Market - Sequencing Solutions, Redefined: Innovations in …
Newark, New Castle, USA - new report, titled NGS Library Preparation Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the NGS Library Preparation market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global NGS Library Preparation market. The report offers an overview of…
Next Generation Sequencing (NGS) Data Analysis Market Research Report 2020Next G …
The Next Generation Sequencing (NGS) Data Analysis Market report helps identify the biggest opportunities in Next Generation Sequencing (NGS) Data Analysis industry space and offers accurate latent demand forecasting that empowers quantitative decision making among Next Generation Sequencing (NGS) Data Analysis market players and new entrants. Investors will gain a clear insight on the dominant players in Next Generation Sequencing (NGS) Data Analysis industry and their future forecasts. Furthermore, readers…